
Robert A. Schwartzman
Examiner (ID: 220)
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636, 1805 |
| Total Applications | 441 |
| Issued Applications | 346 |
| Pending Applications | 61 |
| Abandoned Applications | 34 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 3930792
[patent_doc_number] => 05980911
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-09
[patent_title] => 'Adjuvant'
[patent_app_type] => 1
[patent_app_number] => 8/732398
[patent_app_country] => US
[patent_app_date] => 1997-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 11372
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/980/05980911.pdf
[firstpage_image] =>[orig_patent_app_number] => 732398
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/732398 | Adjuvant | Feb 10, 1997 | Issued |
Array
(
[id] => 4093664
[patent_doc_number] => 06096548
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-01
[patent_title] => 'Method for directing evolution of a virus'
[patent_app_type] => 1
[patent_app_number] => 8/792409
[patent_app_country] => US
[patent_app_date] => 1997-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14606
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/096/06096548.pdf
[firstpage_image] =>[orig_patent_app_number] => 792409
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/792409 | Method for directing evolution of a virus | Feb 2, 1997 | Issued |
Array
(
[id] => 4084621
[patent_doc_number] => 06017734
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-25
[patent_title] => 'Unique nucleotide and amino acid sequence and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/792832
[patent_app_country] => US
[patent_app_date] => 1997-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 47
[patent_no_of_words] => 67163
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/017/06017734.pdf
[firstpage_image] =>[orig_patent_app_number] => 792832
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/792832 | Unique nucleotide and amino acid sequence and uses thereof | Jan 29, 1997 | Issued |
| 08/765551 | DUAL HYBRID SYSTEM | Jan 21, 1997 | Abandoned |
Array
(
[id] => 3685944
[patent_doc_number] => 05695963
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-09
[patent_title] => 'Endothelial PAS domain protein'
[patent_app_type] => 1
[patent_app_number] => 8/785241
[patent_app_country] => US
[patent_app_date] => 1997-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8677
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/695/05695963.pdf
[firstpage_image] =>[orig_patent_app_number] => 785241
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/785241 | Endothelial PAS domain protein | Jan 16, 1997 | Issued |
Array
(
[id] => 3859758
[patent_doc_number] => 05795746
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-18
[patent_title] => 'Synthetic leader peptide sequences'
[patent_app_type] => 1
[patent_app_number] => 8/780571
[patent_app_country] => US
[patent_app_date] => 1997-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 22
[patent_no_of_words] => 11736
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/795/05795746.pdf
[firstpage_image] =>[orig_patent_app_number] => 780571
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/780571 | Synthetic leader peptide sequences | Jan 7, 1997 | Issued |
Array
(
[id] => 3953477
[patent_doc_number] => 05935783
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-10
[patent_title] => 'Genes mapping in the digeorge and velocardiofacial syndrome minimal critical region'
[patent_app_type] => 1
[patent_app_number] => 8/775009
[patent_app_country] => US
[patent_app_date] => 1996-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 19434
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/935/05935783.pdf
[firstpage_image] =>[orig_patent_app_number] => 775009
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/775009 | Genes mapping in the digeorge and velocardiofacial syndrome minimal critical region | Dec 26, 1996 | Issued |
Array
(
[id] => 3871609
[patent_doc_number] => 05837855
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-17
[patent_title] => 'Hairpin ribozymes'
[patent_app_type] => 1
[patent_app_number] => 8/773297
[patent_app_country] => US
[patent_app_date] => 1996-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 30
[patent_no_of_words] => 7625
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/837/05837855.pdf
[firstpage_image] =>[orig_patent_app_number] => 773297
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/773297 | Hairpin ribozymes | Dec 22, 1996 | Issued |
Array
(
[id] => 4376629
[patent_doc_number] => 06303382
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-16
[patent_title] => 'Formation of and methods for the production of large bacillus thuringiensis crystals with increased pesticidal activity'
[patent_app_type] => 1
[patent_app_number] => 8/771190
[patent_app_country] => US
[patent_app_date] => 1996-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10207
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/303/06303382.pdf
[firstpage_image] =>[orig_patent_app_number] => 771190
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/771190 | Formation of and methods for the production of large bacillus thuringiensis crystals with increased pesticidal activity | Dec 19, 1996 | Issued |
Array
(
[id] => 3977516
[patent_doc_number] => 05917013
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-29
[patent_title] => 'Peptides and their use to ameliorate cell death'
[patent_app_type] => 1
[patent_app_number] => 8/759599
[patent_app_country] => US
[patent_app_date] => 1996-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7979
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/917/05917013.pdf
[firstpage_image] =>[orig_patent_app_number] => 759599
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/759599 | Peptides and their use to ameliorate cell death | Dec 4, 1996 | Issued |
Array
(
[id] => 3784314
[patent_doc_number] => 05736334
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-07
[patent_title] => 'Nucleotide sequences and process for amplifying and detection of hepatitis B viral DNA'
[patent_app_type] => 1
[patent_app_number] => 8/758626
[patent_app_country] => US
[patent_app_date] => 1996-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14995
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/736/05736334.pdf
[firstpage_image] =>[orig_patent_app_number] => 758626
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/758626 | Nucleotide sequences and process for amplifying and detection of hepatitis B viral DNA | Nov 26, 1996 | Issued |
| 08/754686 | ANTISENSE OLIGONUCLEOTIDES SPECIFIC FOR CDK4 | Nov 20, 1996 | Abandoned |
Array
(
[id] => 3785021
[patent_doc_number] => 05821352
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-13
[patent_title] => 'CDNA collections encoding proteins regulated during programmed cell death, methods of preparation thereof and methods of use thereof'
[patent_app_type] => 1
[patent_app_number] => 8/751782
[patent_app_country] => US
[patent_app_date] => 1996-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 25
[patent_no_of_words] => 21063
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/821/05821352.pdf
[firstpage_image] =>[orig_patent_app_number] => 751782
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/751782 | CDNA collections encoding proteins regulated during programmed cell death, methods of preparation thereof and methods of use thereof | Nov 17, 1996 | Issued |
Array
(
[id] => 4071787
[patent_doc_number] => 05965389
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-12
[patent_title] => 'Production of GAD65 in methylotrophic yeast'
[patent_app_type] => 1
[patent_app_number] => 8/747108
[patent_app_country] => US
[patent_app_date] => 1996-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18144
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/965/05965389.pdf
[firstpage_image] =>[orig_patent_app_number] => 747108
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/747108 | Production of GAD65 in methylotrophic yeast | Nov 7, 1996 | Issued |
Array
(
[id] => 4028625
[patent_doc_number] => 05994132
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-30
[patent_title] => 'Adenovirus vectors'
[patent_app_type] => 1
[patent_app_number] => 8/735609
[patent_app_country] => US
[patent_app_date] => 1996-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 25
[patent_no_of_words] => 39353
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/994/05994132.pdf
[firstpage_image] =>[orig_patent_app_number] => 735609
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/735609 | Adenovirus vectors | Oct 22, 1996 | Issued |
Array
(
[id] => 3767363
[patent_doc_number] => 05849526
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-15
[patent_title] => 'Use of linalool synthase in genetic engineering of scent production'
[patent_app_type] => 1
[patent_app_number] => 8/732192
[patent_app_country] => US
[patent_app_date] => 1996-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 18583
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/849/05849526.pdf
[firstpage_image] =>[orig_patent_app_number] => 732192
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/732192 | Use of linalool synthase in genetic engineering of scent production | Oct 14, 1996 | Issued |
Array
(
[id] => 3875839
[patent_doc_number] => 05804383
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-08
[patent_title] => 'Method and assay for detection of the expression of allele-specific mutations by allele-specific in situ reverse transcriptase polymerase chain reaction'
[patent_app_type] => 1
[patent_app_number] => 8/727003
[patent_app_country] => US
[patent_app_date] => 1996-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 22
[patent_no_of_words] => 15987
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 344
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/804/05804383.pdf
[firstpage_image] =>[orig_patent_app_number] => 727003
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/727003 | Method and assay for detection of the expression of allele-specific mutations by allele-specific in situ reverse transcriptase polymerase chain reaction | Oct 7, 1996 | Issued |
Array
(
[id] => 3807964
[patent_doc_number] => 05831016
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-03
[patent_title] => 'Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes'
[patent_app_type] => 1
[patent_app_number] => 8/725736
[patent_app_country] => US
[patent_app_date] => 1996-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 14068
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/831/05831016.pdf
[firstpage_image] =>[orig_patent_app_number] => 725736
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/725736 | Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes | Oct 3, 1996 | Issued |
Array
(
[id] => 4028405
[patent_doc_number] => 05994119
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-30
[patent_title] => 'Mammalian regulator of nonsense-mediated RNA decay'
[patent_app_type] => 1
[patent_app_number] => 8/724354
[patent_app_country] => US
[patent_app_date] => 1996-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 14
[patent_no_of_words] => 30684
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/994/05994119.pdf
[firstpage_image] =>[orig_patent_app_number] => 724354
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/724354 | Mammalian regulator of nonsense-mediated RNA decay | Sep 30, 1996 | Issued |
| 08/721730 | METHODS TO IDENTIFY COMPOUNDS FOR DISRUPTING PROTEIN/PROTEIN INTERACTIONS | Sep 26, 1996 | Abandoned |